The FDA approval is important, as we currently do not understand what the long-term health risks a patient may be putting themselves at risk of are
S1c, d), highlighting its role as a potential antioxidant and possible moiety associated with neuroprotective behavior of many nootropic herbs 34
Highdose IV protocols (5001,500 mg daily for ~10 days) have been used in openlabel studies for substance use disorder, with reports of reduced cravings and improved mood in followups [2] [9]
Some practitioners suggest that cryotherapys vasoconstriction followed by reactive vasodilation (increased blood flow after rewarming) may actually enhance BPC-157 distribution to injured tissues
References Campanati A, Marani A, Martina E, Diotallevi F, Radi G, Offidani A